AZD-1656 Uses, Dosage, Side Effects and more
AZD-1656 is under investigation in clinical trial NCT00747175 (A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes).
| Trade Name | AZD-1656 |
| Generic | AZD-1656 |
| Type | |
| Formula | C24H26N6O5 |
| Weight | Average: 478.509 Monoisotopic: 478.196467961 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
